Related Experiment Videos
[Idiopathic hypertrophic cranial pachymeningitis]
Jairo Lizarazo1, Edgar Parra, Patricia Gutiérrez
1Hospital Universitario Erasmo Meoz, Cúcuta, Norte de Santander, Colombia. jflizar@telecom.com.co
Biomedica : Revista Del Instituto Nacional De Salud
|October 22, 2004
Summary
Idiopathic hypertrophic cranial pachymeningitis (IHCP) causes thickening of the dura mater, leading to neurological issues. Early diagnosis via MRI and biopsy, followed by immunosuppressive therapy, is crucial for managing this rare condition.
Area of Science:
- Neurology
- Pathology
Background:
- Idiopathic hypertrophic cranial pachymeningitis (IHCP) is a rare chronic inflammatory condition of unknown cause.
- It leads to thickening of the dura mater, potentially causing progressive neurological deficits due to compression of adjacent structures.
Observation:
- A case of an adult woman presenting with headache, progressive vision loss, and bilateral optic neuropathy is described.
- Neuroimaging revealed thickened dura mater, and histopathological examination excluded other known causes.
Findings:
- Magnetic resonance imaging (MRI) with contrast medium aids in diagnosis and follow-up.
- Dural biopsy remains the gold standard for definitive diagnosis of IHCP.
Implications:
- Corticosteroid therapy often improves symptoms, but relapses are common.
- Combination therapy with immunosuppressants like cyclophosphamide or azathioprine may be necessary.
- While mortality is low, significant neurological sequelae are frequent.